WCN25-4208 COMPARATIVE OUTCOMES OF IVIG MONOTHERAPY VERSUS PLASMAPHERESIS-COMBINED IVIG IN CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION
Chronic active antibody-mediated rejection (ABMR) is a leading cause of long-term graft failure in kidney transplant recipients, characterized by persistent donor-specific antibodies (DSAs) and microvascular inflammation. This study compares the efficacy and safety of intravenous immunoglobulin (IVIG) monotherapy versus plasmapheresis (PLEX) combined with IVIG in managing chronic active ABMR.
Authors
- Sree Bhushan Raju (ORCID: https://orcid.org/0000-0001-9409-3874)
- Nishant Poddar (ORCID: https://orcid.org/0000-0003-0822-4028)
- Rahul R Nair
- Haard Barot
- Abhinaya Balguri
- Ravi Tej Madipalli
Institutions
- Nizam's Institute of Medical Sciences (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.986
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00